Arrivent Biopharma Inc (AVBP)

Dec 10, 2025

ArriVent Biopharma initiated with a Buy at BTIG - TipRanks

Dec 10, 2025

Dec 10, 2025

ArriVent Biopharma initiated with a Buy at BTIG on firmonertinib potential - TipRanks

Dec 10, 2025

Dec 10, 2025

BTIG Initiates ArriVent BioPharma at Buy With $45 Price Target - marketscreener.com

Dec 10, 2025

Dec 09, 2025

ArriVent BioPharma (NASDAQ:AVBP) versus Sunshine Biopharma (NASDAQ:SBFM) Critical Review - Defense World

Dec 09, 2025

Dec 08, 2025

Buy Rating for ArriVent BioPharma, Inc. Driven by Promising Developments in EGFR Exon 20 NSCLC Treatment - TipRanks

Dec 08, 2025

Dec 05, 2025

Is ArriVent BioPharma Inc (AVBP) positioned for future growth? - Setenews

Dec 05, 2025

Dec 03, 2025

Buy Rating for ArriVent BioPharma Driven by Promising Firmonertinib Trial Results - TipRanks

Dec 03, 2025

Dec 03, 2025

ArriVent BioPharma (NASDAQ:AVBP) Shares Down 6.4%Here's What Happened - MarketBeat

Dec 03, 2025

Dec 03, 2025

Understanding Momentum Shifts in (AVBP) - news.stocktradersdaily.com

Dec 03, 2025

Dec 02, 2025

How ArriVent BioPharma Inc. stock trades before earnings2025 Trading Volume Trends & Accurate Trade Setup Notifications - Newser

Dec 02, 2025

Dec 02, 2025

Will ArriVent BioPharma Inc. stock sustain high P E ratiosWeekly Market Outlook & Stepwise Trade Signal Implementation - Newser

Dec 02, 2025

Nov 28, 2025

A new trading data show ArriVent BioPharma Inc (AVBP) is showing positive returns. - Setenews

Nov 28, 2025

Nov 27, 2025

ArriVent BioPharma (NASDAQ:AVBP) Coverage Initiated at Truist Financial - MarketBeat

Nov 27, 2025

Nov 27, 2025

Truist Financial Initiates Coverage on ArriVent BioPharma (NASDAQ:AVBP) - Defense World

Nov 27, 2025

Nov 25, 2025

ArriVent Biopharma initiated with a Buy at Truist - TipRanks

Nov 25, 2025

Nov 25, 2025

ArriVent BioPharma stock initiated with Buy rating at Truist on lung cancer drug - Investing.com Canada

Nov 25, 2025

Nov 25, 2025

Truist Initiates ArriVent BioPharma at Buy With $43 Price Target - marketscreener.com

Nov 25, 2025

Nov 25, 2025

AXQ Capital LP Buys New Position in Intellia Therapeutics, Inc. $NTLA - Defense World

Nov 25, 2025

Nov 25, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Nov 25, 2025

Nov 25, 2025

ArriVent BioPharma, Inc. (NASDAQ:AVBP) Receives Average Rating of “Moderate Buy” from Analysts - Defense World

Nov 25, 2025

Nov 22, 2025

Avoiding Lag: Real-Time Signals in (AVBP) Movement - news.stocktradersdaily.com

Nov 22, 2025

Nov 21, 2025

ArriVent Maps Ambitious 2026 Oncology Push as Firmonertinib Program Gains Steam - MSN

Nov 21, 2025

Nov 20, 2025

Is ArriVent BioPharma Inc. stock in correction or buying zoneCEO Change & Smart Money Movement Alerts - newser.com

Nov 20, 2025

Nov 20, 2025

Can ArriVent BioPharma Inc. stock outperform in 2025 bull marketEarnings Overview Summary & Momentum Based Trading Signals - newser.com

Nov 20, 2025

Nov 19, 2025

Best data tools to analyze ArriVent BioPharma Inc. stockJuly 2025 Big Picture & Smart Swing Trading Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How institutional ownership impacts ArriVent BioPharma Inc. stockWeekly Trade Recap & Stepwise Entry and Exit Trade Signals - newser.com

Nov 19, 2025

Nov 19, 2025

Will ArriVent BioPharma Inc. stock gain from lower inflationWeekly Profit Recap & Reliable Volume Spike Trade Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How ArriVent BioPharma Inc. stock reacts to Fed rate cutsGap Down & High Yield Equity Trading Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Can momentum traders help lift ArriVent BioPharma Inc.Portfolio Value Summary & AI Forecasted Stock Moves - newser.com

Nov 19, 2025

Nov 19, 2025

Published on: 2025-11-19 02:02:03 - newser.com

Nov 19, 2025

Nov 19, 2025

Is ArriVent BioPharma Inc. stock a defensive play in 20252025 Volatility Report & Real-Time Chart Pattern Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

Why Red River Bancshares, Inc. stock attracts strong analyst attention - newser.com

Nov 18, 2025

Nov 18, 2025

Evaluating ArriVent BioPharma Inc. with trendline analysisWeekly Risk Summary & Free Real-Time Market Sentiment Alerts - newser.com

Nov 18, 2025

Nov 18, 2025

Analyzing ArriVent BioPharma Inc. with risk reward ratio chartsJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com

Nov 18, 2025

Nov 15, 2025

Published on: 2025-11-15 15:01:05 - newser.com

Nov 15, 2025

Nov 14, 2025

Why ArriVent BioPharma Inc. stock is favored by pension fundsLong Setup & Accurate Entry/Exit Alerts - newser.com

Nov 14, 2025

Nov 14, 2025

Momentum divergence signals in ArriVent BioPharma Inc. chartWeekly Stock Recap & Real-Time Volume Analysis - newser.com

Nov 14, 2025

Nov 14, 2025

What is the fair value of ArriVent BioPharma Inc. stock now2025 Earnings Impact & Fast Gain Stock Tips - Fundação Cultural do Pará

Nov 14, 2025

Nov 14, 2025

What is HC Wainwright’s Forecast for AVBP FY2025 Earnings? - Defense World

Nov 14, 2025

Nov 13, 2025

Here's Why We're Watching ArriVent BioPharma's (NASDAQ:AVBP) Cash Burn Situation - Sahm

Nov 13, 2025